Skip to main content
. 2012 May 23;167(2):287–294. doi: 10.1530/EJE-12-0293

Figure 3.

Figure 3

(A) Percentage of subjects achieving HbA1c targets of <7.0 and ≤6.5% at the end of the trial. (B) Percentage of subjects treated for at least 8 weeks achieving HbA1c targets of <7.0 and ≤6.5% at the end of the trial in the absence of confirmed hypoglycaemia in the last 4 weeks of treatment. Without hypo = no confirmed hypoglycaemia (PG <3.1 mmol/l) in the last 4 weeks of treatment; *significant difference (IDegAsp vs BIAsp 30).